Login to MyKarger

New to MyKarger? Click here to sign up.

Login with Facebook

Forgot Password? Reset your password

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login (Shibboleth)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.

Table of Contents
Vol. 37, No. 2, 2010
Issue release date: April 2010
Section title: Review Article · Übersichtsarbeit
Free Access
Transfus Med Hemother 2010;37:66–73

Use of Encapsulated Stem Cells to Overcome the Bottleneck of Cell Availability for Cell Therapy Approaches

Freimark D.a · Pino-Grace P.P.a · Pohl S.a · Weber C.a · Wallrapp C.b · Geigle P.b · Pörtner R.c · Czermak P.a, d
a Institute of Biopharmaceutical Technology, University of Applied Sciences, Gießen b CellMed AG, Alzenau c Institute of Bioprocess and Biosystems Engineering, University of Technology, Hamburg, Germany d Department of Chemical Engineering, Kansas State University, Manhattan, KS, USA
email Corresponding Author

Prof. Dr.-Ing. Peter Czermak, Institut für Biopharmazeutische Technologie, Fachhochschule Gießen-Friedberg, Wiesenstraße 14, 35390 Gießen, Germany, Tel. +49 641 309 25-51, -Fax -53, peter.czermak@tg.fh-giessen.de

Do you have an account?

Login Information

Contact Information

I have read the Karger Terms and Conditions and agree.


Nowadays cell-based therapy is rarely in clinical practice because of the limited availability of appropriate cells. To apply cells therapeutically, they must not cause any immune response wherefore mainly autologous cells have been used up to now. The amount of vital cells in patients is limited, and under certain circumstances in highly degenerated tissues no vital cells are left. Moreover, the extraction of these cells is connected with additional surgery; also the expansion in vitro is difficult. Other approaches avoid these problems by using allo-or even xenogenic cells. These cells are more stable concerning their therapeutic behavior and can be produced in stock. To prevent an immune response caused by these cells, cell encapsulation (e.g. with alginate) can be performed. Certain studies showed that encapsulated allo-and xenogenic cells achieve promising results in treatment of several diseases. For such cell therapy approaches, stem cells, particularly mesenchymal stem cells, are an interesting cell source. This review deals on the one hand with the use of encapsulated cells, especially stem cells, in cell therapy and on the other hand with bioreactor systems for the expansion and differentiation of mesenchymal stem cells in reproducible and sufficient amounts for potential clinical use.

© 2010 S. Karger AG, Basel

Article / Publication Details

First-Page Preview
Abstract of Review Article · Übersichtsarbeit

Received: September 28, 2009
Accepted: December 29, 2009
Published online: March 08, 2010
Issue release date: April 2010

Number of Print Pages: 8
Number of Figures: 0
Number of Tables: 0

ISSN: 1660-3796 (Print)
eISSN: 1660-3818 (Online)

For additional information: http://www.karger.com/TMH

Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.